Mediclinic invests more than Dh120 million at Airport Road Hospital in Abu Dhabi
Mediclinic Middle East, one of the UAE's leading private healthcare providers with operations in Abu Dhabi, Al Ain and Dubai, announced an investment of more than Dh120 million at its flagship Abu Dhabi facility, Mediclinic Airport Road Hospital.
The investment will be used to expand and enhance healthcare infrastructure at the hospital to further strengthen access to high-quality medical services for patients and their families across the emirate.
The announcement was made during Abu Dhabi Global Health Week 2025, a major government initiative by the Department of Health – Abu Dhabi that seeks to advance the future of health and well-being.
The expansion project, which is under way, includes the development of several key areas within the hospital, including additional consulting rooms, an expanded theatre complex, new endoscopy suites and increased capacity for day-care beds. The project will also see the introduction of additional labour and delivery rooms, along with an increase in capacity for its Neonatal Intensive Care Unit.
Hein van Eck, chief executive of Mediclinic Middle East, said: 'This investment marks a significant step in our mission to meet the evolving healthcare needs of the Abu Dhabi community.
"Ever since we entered the Abu Dhabi market in 2016, Mediclinic has worked to expand and improve its facilities and service offerings, not only enhancing patient care, but also supporting the Department of Health's commitment to innovation and long-term health system sustainability.'
This expansion reflects Mediclinic's ongoing commitment to delivering world-class healthcare services in Abu Dhabi and to significantly enhancing the patient experience by improving accessibility and the range of specialist care available.
The upgraded infrastructure aligns with the Department of Health's strategic priorities, including empowering a health-conscious population, providing access to best-in-class care, and delivering high-quality outcomes and experience, as a globally competitive health and life sciences sector.
Mediclinic Airport Road Hospital was established in 2008 and provides a wide range of advanced inpatient and outpatient services. It underwent significant redevelopment and expansion in 2021 with the addition of a building which more than doubled the size of the existing hospital, and included the addition of a state-of-the-art comprehensive cancer centre.
Construction on the new project has begun with a phased implementation over the coming months, while all existing services continue uninterrupted. Completion is expected by early 2026.
More information about Mediclinic Middle East is at www.mediclinic.ae.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arabian Business
6 hours ago
- Arabian Business
UAE healthcare giant Mediclinic merges two major Abu Dhabi hospitals
Mediclinic Middle East has announced the consolidation of its two Abu Dhabi hospitals – Mediclinic Al Noor Hospital and Mediclinic Airport Road Hospital – into a single facility at the expanded Airport Road campus. The healthcare provider will phase out operations at Mediclinic Al Noor Hospital and transfer clinical services and expertise to the enhanced Mediclinic Airport Road Hospital location. The consolidation aims to strengthen operational efficiency and service delivery. Mediclinic creates 265-bed medical campus in Abu Dhabi consolidation 'After a comprehensive review of how we can best serve the future of healthcare in Abu Dhabi, we made the strategic decision to consolidate two of its most respected institutions – Mediclinic Al Noor and Mediclinic Airport Road Hospitals – into a single, integrated next-generation medical campus. This consolidation aligns with our long-term vision and supports the government's ambitions for a healthcare system rooted in innovation, qualityand accessibility,' Hein van Eck, CEO, Mediclinic Middle East said. The new consolidated facility spans more than 74,000 square metres and features 265 beds, supported by an AED 120 million investment. The expanded campus provides patients with access to a healthcare pathway from preventive and primary care through to specialised tertiary services. The facility brings together medical experts, medical technology, upgraded operating theatres and specialised units in oncology, cardiovascular, surgery, musculoskeletal, ophthalmology and women's health within a multidisciplinary environment focusing on quality, safety and patient experience. The decision reflects Mediclinic's commitment to the Abu Dhabi Healthcare Strategic Plan and the Department of Health's focus on healthcare services, patient safety and experience. The company states its goal is to achieve outcomes through clinical collaboration and improved resourcing whilst delivering patient experience in a healthcare environment. Mediclinic said Al Noor Hospital's structural constraints limit its ability to evolve in line with Mediclinic Middle East's vision for clinical care, patient experience and infrastructure. The move enables Mediclinic to build upon the trust and legacy of the Al Noor name whilst providing services at a facility aligned with healthcare standards. 'This transition enables us to honour and preserve Al Noor's extraordinary legacy while significantly enhancing patient care at the new, expanded Airport Road facility. We are undertaking this consolidation with immense care, humility and responsibility. Every patient, every team member and every relationship at Al Noor matters deeply to us. Our commitment to each of them remains unwavering, and we will proactively engage patients, staff and partners with personalised plans to ensure clarity, continuity and compassion throughout this process,' Van Eck added. Van Eck thanked each physician, nurse, administrator, patient and family member who has used Mediclinic Al Noor Hospital, stating they are part of its legacy, which will continue in the next chapter. 'Together, we are not merely building a hospital; we are creating a future that honours our past while embracing the possibilities ahead,' Van Eck concluded. Mediclinic remains committed to the Department of Health – Abu Dhabi as a healthcare partner and to working with them to deliver their vision for access to healthcare through clinical excellence and regulatory enhancement. The company describes the consolidation as an investment in value, clinical innovation and the community it serves. The transfer of patients and healthcare teams is underway. Mediclinic will contact patients whose appointments are affected. Patients requiring assistance or information can call 800 2027.
Al Etihad
a day ago
- Al Etihad
Abu Dhabi reinforces global leadership in healthcare innovation with high-level US visit
15 June 2025 17:41 ABU DHABI (WAM) A high-level delegation led by the Department of Health – Abu Dhabi (DoH), is set to embark on a strategic mission to the United States from June 14-21, visit reaffirms Abu Dhabi's global leadership in healthcare innovation and reflects its broader vision for healthcare transformation—driven by innovation, investment, and a deep commitment to global delegation will visit key US cities including Boston, Washington D.C., and Philadelphia, in parallel with Abu Dhabi's participation at BIO International Convention 2025, one of the world's foremost biotechnology visit will spotlight the Emirate's achievements in AI, digital health, genomics, and clinical research and showcase Abu Dhabi's Health, Endurance, Longevity and Medicine (HELM) Life Science Cluster, while promoting long-term strategic partnerships with government entities, research institutions, and global Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, stated, 'This mission reflects our commitment to shaping the future of health through collaboration, innovation, and shared purpose. Our vision is to build a health system that predicts, prevents, acts to restore, and acts to cure, therefore ensuring better outcomes for our communities and beyond. "This can only be achieved through meaningful partnerships and a shared ambition to improve lives. We are proud to join our partners in the United States to explore new opportunities that advance healthcare, both in the UAE and globally.'The delegation will conduct over 20 strategic meetings and visits with public and private sector leaders across the US, aimed at knowledge exchange, investment opportunities, and the signing of new agreements that accelerate the adoption of advanced health Abu Dhabi's innovation ecosystem, the delegation includes key stakeholders such as the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, and Etihad Dhabi continues to lead the region in genomics through the Emirati Genome Programme, which has successfully sequenced over 800,000 samples, creating one of the most advanced national genomic databases. The Emirate is also home to more than 90 licenced research centers and 30+ ongoing clinical trials in areas such as oncology, rare diseases, and chronic conditions. Advanced data platforms such as Malaffi, which securely store over 5 million patient records—enable AI-powered insights and real-world evidence, while national initiatives like the Golden Visa programme are cultivating a global workforce and have granted over 2,000 long-term visas for researchers and healthcare professionals from around the world.
Zawya
a day ago
- Zawya
Abu Dhabi reinforces global leadership in healthcare innovation with high-level U.S. visit
Abu Dhabi, United Arab Emirates – A high-level delegation led by the Department of Health – Abu Dhabi (DoH), is set to embark on a strategic mission to the United States from June 14 to 21, 2025. The visit reaffirms Abu Dhabi's global leadership in healthcare innovation and reflects its broader vision for healthcare transformation—driven by innovation, investment, and a deep commitment to global collaboration. The delegation will visit key U.S. cities including Boston, Washington D.C., and Philadelphia, in parallel with Abu Dhabi's participation at BIO International Convention 2025, one of the world's foremost biotechnology events. The visit will spotlight the Emirate's achievements in AI, digital health, genomics, and clinical research and showcase Abu Dhabi's Health, Endurance, Longevity and Medicine (HELM) Life Science Cluster, while promoting long-term strategic partnerships with government entities, research institutions, and global innovators. H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, stated: 'This mission reflects our commitment to shaping the future of health through collaboration, innovation, and shared purpose. Our vision is to build a health system that predicts, prevents, acts to restore, and acts to cure, therefore ensuring better outcomes for our communities and beyond. This can only be achieved through meaningful partnerships and a shared ambition to improve lives. We are proud to join our partners in the United States to explore new opportunities that advance healthcare, both in the UAE and globally.' The delegation will conduct over 20 strategic meetings and visits with public and private sector leaders across the U.S., aimed at knowledge exchange, investment opportunities, and the signing of new agreements that accelerate the adoption of advanced health solutions. Representing Abu Dhabi's innovation ecosystem, the delegation includes key stakeholders such as the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, and Etihad Cargo. Abu Dhabi continues to lead the region in genomics through the Emirati Genome Programme, which has successfully sequenced over 800,000 samples, creating one of the most advanced national genomic databases. The Emirate is also home to more than 90 licensed research centers and 30+ ongoing clinical trials in areas such as oncology, rare diseases, and chronic conditions. Advanced data platforms such as Malaffi, which securely store over 5 million patient records—enable AI-powered insights and real-world evidence, while national initiatives like the Golden Visa program are cultivating a global workforce and have granted over 2,000 long-term visas for researchers and healthcare professionals from around the world. About the Department of Health – Abu Dhabi (DoH): The Department of Health – Abu Dhabi is the regulative body of the healthcare sector in the Emirate of Abu Dhabi. Committed to ensuring excellence in healthcare, DoH monitors the health status of the population while shaping the regulatory framework for the health system. This includes inspecting against regulations, enforcing standards and encouraging the adoption of world-class best practices and performance targets by all healthcare providers in the Emirate. Abu Dhabi remains dedicated to shaping the future of healthcare by establishing an intelligent and sustainable ecosystem that prioritises health, longevity and quality of life for all community members. Leveraging state-of-the-art infrastructure and cutting-edge capabilities, DoH continues to develop and implement initiatives and programmes in line with its strategic focus areas, Healthy Population, Best-in-Class Care and Resilience and Innovation. These efforts reflect DoH's unwavering commitment to predicting, preventing and personalising healthcare for every individual. For further information on DOH, visit and follow on X, Instagram, Facebook, LinkedIn and YouTube. For media inquiries, please contact: Mariam Al Marzooqi, msalmarzooqi@
